Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force

For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and weight gain with some SUs have led to discussion on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Endocrinol Metab
Main Authors: Kalra, Sanjay, Bahendeka, Silver, Sahay, Rakesh, Ghosh, Sujoy, Md, Fariduddin, Orabi, Abbas, Ramaiya, Kaushik, Al Shammari, Sameer, Shrestha, Dina, Shaikh, Khalid, Abhayaratna, Sachitha, Shrestha, Pradeep K., Mahalingam, Aravinthan, Askheta, Mazen, A. Rahim, Aly Ahmed, Eliana, Fatimah, Shrestha, Hari K., Chaudhary, Sandeep, Ngugi, Nancy, Mbanya, Jean Claude, Aye, Than Than, Latt, Tint Swe, Akanov, Zhanay A., Syed, Abbas Raza, Tandon, Nikhil, Unnikrishnan, A. G., Madhu, S. V., Jawa, Ali, Chowdhury, Subhankar, Bajaj, Sarita, Das, Ashok Kumar
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2018
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
https://ncbi.nlm.nih.gov/pubmed/29535952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijem.IJEM_556_17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados